-
Name
Cibenzoline succinate
- EINECS
- CAS No. 100678-32-8
- Density g/cm3
- Solubility
- Melting Point 165°
- Formula C18H18N2.C4H6O4
- Boiling Point 449.2°Cat760mmHg
- Molecular Weight 380.44
- Flash Point 225.5°C
- Transport Information
- Appearance
-
Safety
Hazard Codes Xn Risk Statements 22 RTECS EJ9960100 - Risk Codes R22
-
Molecular Structure
-
Hazard Symbols
- Synonyms 2-(2,2-Diphenylcyclopropyl)-4,5-dihydro-1H-imidazole succinate
- PSA 98.99000
- LogP 2.69450
Cibenzoline succinate Chemical Properties
IUPAC Name: Butanedioic acid; 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole
Canonical SMILES: C1CN=C(N1)C2CC2(C3=CC=CC=C3)C4=CC=CC=C4.C(CC(=O)O)C(=O)O
InChI: InChI=1S/C18H18N2.C4H6O4/c1-3-7-14(8-4-1)18(15-9-5-2-6-10-15)13-16(18)17-19-11-12-20-17;5-3(6)1-2-4(7)8/h1-10,16H,11-13H2,(H,19,20);1-2H2,(H,5,6)(H,7,8)
InChIKey: XFUIOIWYMHEPIE-UHFFFAOYSA-N
Molecular Weight: 380.43696 [g/mol]
Molecular Formula: C22H24N2O4
H-Bond Donor: 3
H-Bond Acceptor: 6
EINECS: 260-856-8
Product Categories: Heterocyclic Compounds
storage temp.: 2-8 °C
Flash Point: 225.5 °C
Enthalpy of Vaporization: 68.06 kJ/mol
Boiling Point: 449.2 °C at 760 mmHg
Vapour Pressure: 7.75E-08 mmHg at 25 °C
Classification Code of Cibenzoline succinate (CAS NO.100678-32-8): Cardiac depressant [anti-arrhythmic]; Drug / Therapeutic Agent; Reproductive Effect
Cibenzoline succinate Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
| dog | LD | oral | > 56mg/kg (56mg/kg) | BEHAVIORAL: TREMOR | Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4519, 1988. |
| dog | LD50 | intravenous | 33300ug/kg (33.3mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) | Kiso to Rinsho. Clinical Report. Vol. 25, Pg. 3385, 1991. |
| mouse | LD50 | intraperitoneal | 73100ug/kg (73.1mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE | Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988. |
| mouse | LD50 | oral | 180mg/kg (180mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE | Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988. |
| mouse | LD50 | subcutaneous | 83300ug/kg (83.3mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE | Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988. |
| rat | LD50 | intraperitoneal | 83400ug/kg (83.4mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE | Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988. |
| rat | LD50 | intravenous | 44400ug/kg (44.4mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE | Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988. |
| rat | LD50 | oral | 359mg/kg (359mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE | Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988. |
| rat | LD50 | subcutaneous | 156mg/kg (156mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE | Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988. |
Cibenzoline succinate Safety Profile
Hazard Codes: 
Xn
Risk Statements: 22
R22:Harmful if swallowed.
RTECS of Cibenzoline succinate (CAS NO.100678-32-8): EJ9960100
Cibenzoline succinate Specification
Cibenzoline succinate (CAS NO.100678-32-8), its Synonyms are (+-)-2-(2,2-Diphenylcyclopropyl)-2-imidazoline succinate (1:1) ; 1H-Imidazole, 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-, (+-)-, butanedioate (1:1) ; 1H-Imidazole, 4,5-dihydro-2-(2,2-diphenylcyclopropyl)-, succinate ; 4,5-Dihydro-2-(2,2-diphenylcyclopropyl)-1H-imidazole succinate ; Cibenzoline succinate (1:1) ; Cipralan ; Ritmalan ; Butanedioic acid, compd. with 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole (1:1) .
Related Products
- Cibenzoline
- Cibenzoline succinate
- 100678-82-8
- 10068-07-2
- 100684-25-1
- 100684-32-0
- 100684-36-4
- 100-68-5
- 1006876-23-8
- 1006876-27-2
- 1006876-28-3
- 1006878-14-3
Hot Products
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View